Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-338071
Filing Date
2026-08-06
Accepted
2026-08-06 16:16:15
Documents
14
Effectiveness Date
2026-08-06

Document Format Files

Seq Description Document Type Size
1 S-8 trvi-20260806.htm S-8 109158
2 EX-5.1 trvi-ex5_1.htm EX-5.1 14116
3 EX-23.2 trvi-ex23_2.htm EX-23.2 3186
4 EX-FILING FEES trvi_exfilingfees.htm   iXBRL EX-FILING FEES 36190
5 GRAPHIC img109914091_0.jpg GRAPHIC 13959
  Complete submission text file 0001193125-26-338071.txt   309663

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT trvi_exfilingfees_htm.xml XML 8877
Mailing Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 16TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-298056 | Film No.: 261249313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)